Colorado biotech startup launches from stealth with $60M Series A


The startup researches and develops new drugs for cancer patients that currently lack treatment options.

Previous Bellevue's expanded MFTE program yields early results, but gaps remain
Next Bryce Olson, precision medicine advocate and former Intel exec, dies at 53